Showing results (1631-1640 of 6,511) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|May 18, 2010
Bioactivity and pharmacokinetics of two human serum albumin-thymosin alpha1-fusion proteins, rHSA-Talpha1 and rHSA-L-Talpha1, expressed in recombinant Pichia pastorisJian-Hua Chen, Xin-Guo Zhang, Yu-Tao Jiang, et al.Cancer Immunology, Immunotherapy : CII|August 31, 2010
Immunization with a recombinant GnRH vaccine fused to heat shock protein 65 inhibits mammary tumor growth in vivoXue Jun Wang, Kai Gu, Jin Shu Xu, et al.Cancer Immunology, Immunotherapy : CII|June 22, 2010
Modeling flow cytometry data for cancer vaccine immune monitoringJacob Frelinger, Janet Ottinger, Cécile Gouttefangeas, et al.Cancer Immunology, Immunotherapy : CII|June 22, 2010
Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase I studyShimon Slavin, Aliza Ackerstein, Reuven Or, et al.Cancer Immunology, Immunotherapy : CII|July 15, 2010
Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansionStephanie L Goff, Laura A Johnson, Mary A Black, et al.Cancer Immunology, Immunotherapy : CII|August 14, 2010
Human papillomavirus type 16 E6-specific antitumor immunity is induced by oral administration of HPV16 E6-expressing Lactobacillus casei in C57BL/6 miceTae-Young Lee, Yang-Hyun Kim, Kyung-Soon Lee, et al.Cancer Immunology, Immunotherapy : CII|September 3, 2010
Evaluation of the immunogenicity of a single chain chimeric peptide composed of hCGβ and oLHα for inhibition of the growth of hCGβ-expressing cancer cellsChu Jiang, Yahong Jiang, Zheping Huang, et al.Cancer Immunology, Immunotherapy : CII|June 10, 2010
IL-12 enhances efficacy and shortens enrichment time in cytokine-induced killer cell immunotherapyMike W Helms, Jennifer A Prescher, Yu-An Cao, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1990
Modulation of the cell-mediated immune function by interferon alpha, beta or gamma can partially reverse the immunosuppression induced by human T-cell leukemia virus I in human cord blood culturesC D'Onofrio, C D Pesce, T Fontana, et al.Cancer Immunology, Immunotherapy : CII|August 21, 2010
Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancerJingting Jiang, Yibei Zhu, Changping Wu, et al.Pageof 652